Serum OPG levels were significantly higher in chronic ADT users and former ADT users as compared to PCa controls (404.56 pg/mL and 426.51 pg/mL vs 329.90 pg/mL, p = 0.012 and p = 0.013, respectively) (Table 2). Here, TNFRSF11B is linked to posterior cortical atrophy.